JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M502964200 on June 14, 2005

J. Biol. Chem., Vol. 280, Issue 32, 28959-28965, August 12, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/32/28959    most recent
M502964200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pashov, A.
Right arrow Articles by Kieber-Emmons, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pashov, A.
Right arrow Articles by Kieber-Emmons, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Antigenic Properties of Peptide Mimotopes of HIV-1-associated Carbohydrate Antigens*

Anastas Pashov{ddagger}§, Gabriela Canziani§, Behjatolah Monzavi-Karbassi{ddagger}, Srini V. Kaveri||, Stewart MacLeod{ddagger}, Rinku Saha{ddagger}, Marty Perry**, Thomas C. VanCott{ddagger}{ddagger}, and Thomas Kieber-Emmons{ddagger}§§

From the {ddagger}Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, Centocor, Inc., Radnor, Pennsylvania 19087, the **Department of Chemistry, Ouachita Baptist University, Arkadelphia, Arkansas 71998, {ddagger}{ddagger}Advanced BioScience Laboratories, Inc., Kensington, Maryland 20895, and ||INSERM U681, Immunopathologie et Immunointervention Thérapeutique, Institut Biomédical des Cordeliers, 75006 Paris, France

The glycan shield of the human immunodeficiency virus (HIV) envelope protein presents many potential epitopes for vaccine development. To augment immune responses to HIV, type 1 (HIV-1), envelope-associated carbohydrate antigens, we are defining peptide mimics of HIV-associated carbohydrate antigens that function as antigen mimotopes that upon immunization will induce antibodies cross-reactive with carbohydrate antigens. We have previously defined peptides with a putative sequence tract RYRY that mimic concanavalin A-binding glycans. To imitate the multivalent binding of carbohydrates, we compared the avidity of a linear (911) and cyclic peptide (D002) reactive with concanavalin A presented in a multiple antigen peptide (MAP) format. The affinity of the MAP-D002 peptide was higher than that of the peptide MAP-911, whereas the avidity of D002 peptide was lower than that of 911. Serum from mice immunized with MAP-911 had lower titer for oligomannose-9 than those elicited by MAP-D002 under the same conditions, but both immunogens elicited antibodies that can block the binding of GP120 to dendritic cells. Antibodies that bind to the studied MAPs were found in a preparation of normal human immunoglobulin for intravenous use. Those that were purified on 911 bound back to 911 and D002, whereas anti-D002 antibodies were specific only for D002. Human antibodies reactive with both mimotopes and with a mannosyl preparation were observed to bind to envelope protein. These results suggested the potential to fine-tune the antibody response to carbohydrate antigens by modifying structural features of peptide mimotope-based immunogens.


Received for publication, March 17, 2005 , and in revised form, May 23, 2005.

* This work was supported by National Institutes of Health Grant R01AI049092, the Arkansas BRIN Program, and the Arkansas BioSciences Institute. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Both authors contributed equally to this work.

§§ To whom correspondence should be addressed: Dept. of Pathology, ACRC No. 824, University of Arkansas for Medical Sciences, 4301 Markham St., Little Rock, AR 72205. E-mail: tke{at}uams.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. D. Pashov, J. Plaxco, S. V. Kaveri, B. Monzavi-Karbassi, D. Harn, and T. Kieber-Emmons
Multiple Antigenic Mimotopes of HIV Carbohydrate Antigens: Relating Structure and Antigenicity
J. Biol. Chem., October 6, 2006; 281(40): 29675 - 29683.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Perosa, E. Favoino, M. A. Caragnano, and F. Dammacco
Generation of biologically active linear and cyclic peptides has revealed a unique fine specificity of rituximab and its possible cross-reactivity with acid sphingomyelinase-like phosphodiesterase 3b precursor
Blood, February 1, 2006; 107(3): 1070 - 1077.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.